-
公开(公告)号：WO2005110410A3
公开(公告)日：2007-03-29
申请号：PCT/US2005016903
申请日：2005-05-13
Applicant: ABBOTT LAB , CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
Inventor： CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
IPC: C07D471/02 , A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
CPC classification number: C07D471/04 , A61K31/4743 , C07D487/04 , C07D491/04 , C07D495/04
Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
Abstract translation: 式（I）的化合物或其药学上可接受的盐，其中取代基如本文所定义，其可用作激酶抑制剂。
-
公开(公告)号：WO2007117465A3
公开(公告)日：2008-08-28
申请号：PCT/US2007008307
申请日：2007-04-02
Applicant: ABBOTT LAB , ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
Inventor： ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
IPC: A61K31/5377
CPC classification number: C07D487/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D409/14
Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
Abstract translation: 式（I）的新型化合物或其药学上可接受的盐，前体药物和式（I）的生物活性代谢物，其中取代基如本文所定义，其可用作治疗剂。
-
公开(公告)号：EP1753428A4
公开(公告)日：2010-09-15
申请号：EP05778736
申请日：2005-05-13
Applicant: ABBOTT LAB
Inventor： CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , WISHART NEIL , YU ZHENGTIAN
IPC: C07D471/02 , A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
CPC classification number: C07D471/04 , A61K31/4743 , C07D487/04 , C07D491/04 , C07D495/04
Abstract: A compound or pharmaceutically acceptable salts thereof of Formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
-
公开(公告)号：EP2001480A4
公开(公告)日：2011-06-15
申请号：EP07754773
申请日：2007-04-02
Applicant: ABBOTT LAB
Inventor： ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
IPC: A61K31/196 , A61P35/00 , C07D403/12
CPC classification number: C07D487/04 , C07D403/12 , C07D403/14 , C07D409/04 , C07D409/14
-
Patent Agency Ranking
公开(公告)号：CA2644910A1
公开(公告)日：2007-10-18
申请号：CA2644910
申请日：2007-04-02
Applicant: ABBOTT LAB
Inventor： ABBOTT LILY K , CUSACK KEVIN P , ARGIRIADI MARIA A , CALDERWOOD DAVID J , ZHANG XIAOLEI , MULLEN KELLY D , DIXON RICHARD W , GORDON THOMAS D , TALANIAN ROBERT V , WANG LU X , LI BIQIN , WU XIAOYUN , FRANK KRISTINE E , BORHANI DAVID W , ERICSSON ANNA M , BURCHAT ANDREW , WISHART NEIL , BARBERIS CLAUDE E
IPC: A61K31/5377
Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
-
公开(公告)号：CA2566158A1
公开(公告)日：2005-11-24
申请号：CA2566158
申请日：2005-05-13
Applicant: ABBOTT LAB
Inventor： BISCHOFF AGNIEZKA K , ERICSSON ANNA M , FRIEDMAN MICHAEL M , GORDON THOMAS D , YU ZHENGTIAN , WISHART NEIL , ROTH GREGORY P , WALLACE GRIER A , BARBERIS CLAUDE E , GEORGE DAWN M , TALANIAN ROBERT V , SALMERON-GARCIA JOSE-ANDRES , CUSACK KEVIN , ALLEN HAMISH J , THOMAS CHRISTINE
IPC: A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
-
公开(公告)号：MXPA06013250A
公开(公告)日：2007-02-28
申请号：MXPA06013250
申请日：2005-05-13
Applicant: ABBOTT LAB
Inventor： WISHART NEIL , ERICSSON ANNA M , CUSACK KEVIN , SALMERON-GARCIA JOSE-ANDRES , GORDON THOMAS D , BARBERIS CLAUDE E , ALLEN HAMISH J , BISCHOFF AGNIESZKA K , FRIEDMAN MICHAEL M , GEORGE DAWN M , ROTH GREGORY P , TALANIAN ROBERT V , THOMAS CHRISTINE , WALLACE GRIER A , YU ZHENGTIAN
IPC: A61K31/4743 , C07D471/04 , C07D491/04 , C07D495/04 , C07D498/02
Abstract: Un compuesto o sales farmaceuticamente aceptables del mismo de la Formula (I), en donde los sustituyentes son como se definen en la presente, los cuales son utiles como inhibidores de quinasa.
-
公开(公告)号：CA2644910C
公开(公告)日：2014-01-28
申请号：CA2644910
申请日：2007-04-02
Applicant: ABBOTT LAB
Inventor： ERICSSON ANNA M , BURCHAT ANDREW , FRANK KRISTINE E , CALDERWOOD DAVID J , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , DIXON RICHARD W , GORDON THOMAS D , MULLEN KELLY D , TALANIAN ROBERT V , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X , LI BIQIN , BARBERIS CLAUDE E , WISHART NEIL
IPC: A61K31/5377
Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
-
公开(公告)号：MX2008012482A
公开(公告)日：2008-10-10
申请号：MX2008012482
申请日：2007-04-02
Applicant: ABBOTT LAB
Inventor： CALDERWOOD DAVID J , WISHART NEIL , DIXON RICHARD W , ERICSSON ANNA M , LI BIQIN , GORDON THOMAS D , BARBERIS CLAUDE E , TALANIAN ROBERT V , FRANK KRISTINE E , BURCHAT ANDREW , ABBOTT LILY K , ARGIRIADI MARIA A , BORHANI DAVID W , CUSACK KEVIN P , MULLEN KELLY D , WU XIAOYUN , ZHANG XIAOLEI , WANG LU X
IPC: A61K31/5377
Abstract: Se describen nuevos compuestos de fórmula (I) o sales farmacéuticamente aceptables, profármacos y metabilitos biológicamente activos de los mismos de fórmula (I), en donde los sustituyentes son según lo definido en la presente, los cuales son útiles como agentes terapéuticos.
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.02 seconds)
